INPLASY202530014

Clinical Insights into IL-23 Inhibition: Risankizumab for Crohn's Disease Through a Systematic Review and Meta-Analysis of Randomized Controlled Trials

Keywords: Crohn's disease; Risankizumab; IL-23 inhibitors; Meta-analysis; Clinical remission; Endoscopic remission.

Read and download full-text here - PDF 202530014

Review Status: completed but not published